close
چهارشنبه 29 شهريور 1396-
 
Links
Home > Archive > News-Archive 
News > The innovation and technology challenge of Iran in the field of creating diagnostic kits for determining HLA will be held.


  Print        Send to Friend

With the Support of Stem Cells Sciences and Technologies Development Headquarter of the Vice-Presidency for Science Affairs;

The innovation and technology challenge of Iran in the field of creating diagnostic kits for determining HLA will be held.

The stem cells sciences and technologies development headquarter of the vice-presidency for science affairs has aimed to perform an innovation and technology competition for producing diagnostic kits for determining HLA in Iran.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, given the growth of Iran’s population and changes in their age pyramid, and increased prevalence of diseases, which require hematopoietic stem cell transplantation, determining HLA and producing diagnostic kits in this regard are of paramount importance.

With this background, the stem cells sciences and technologies development headquarter of the vice-presidency for science affairs will hold an innovation challenge for creating diagnostic kits for determining HLA. In this event, all knowledge-based companies, students, faculty members of universities and research centers, as well as researchers and technologists can participate in the form of individual or group.

According to this report, diagnostic kit\s for determining HLA has many applications for hematopoietic stem cell transplantation since HLA mismatch between donor and recipient not only leads to transplant rejection, but can also lead to the attack of transplanted cells to the host cells.

In addition, about 70% of patients, who need to receive hematopoietic stem cells, cannot find a suitable match among their family members. Therefore, application of compatible unrelated donor stem cells has been doubled in the country, leading to the development of HLA banks in Iran.

According to this report, the produced kit must have the required sensitivity similar to foreign kits in the market, being able to specifically determine HLA. Moreover, the prepared kit must not require foreign software for final evaluation, so that lack of continued cooperation with the foreign company does not lead to problems in designing, producing and interpreting the results.

 

Furthermore, the projects have been sent on April 21st to be entered into the technology challenge, the best projects will be selected on July 1st 2017 and seminar of commercialization education workshop will be held on July 8th 2017.


13:41 - 14/05/2017    /    Number : 23586    /    Show Count : 42







Copyright © Vice-Presidency for Science and Technology. All rights reserved